Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.20+0.07 (+0.77%)
Close on Nov 17, 2026Market cap $821.53MP/E –Yield –
Syndax Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Syndax Pharmaceuticals's price to book ratio was 56.6× on Nov 11, 2026, against 14.9× a year earlier. Over the last 5 years it ranged from 2.1× to 113.9×, with a median of 3.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 56.6× | +40.8 |
| 2025 | Dec 31, 2025 | 15.8× | +12.7 |
| 2024 | Dec 31, 2024 | 3.1× | −1.1 |
| 2023 | Dec 29, 2023 | 4.2× | −0.3 |
| 2022 | Dec 30, 2022 | 4.5× | −0.8 |
| 2021 | Dec 31, 2021 | 5.4× | −1.2 |
| 2020 | Dec 31, 2020 | 6.5× | +1.1 |
| 2019 | Dec 31, 2019 | 5.4× | +3.7 |
| 2018 | Dec 31, 2018 | 1.7× | −0.4 |
| 2017 | Dec 29, 2017 | 2.0× | +0.6 |
| 2016 | Dec 30, 2016 | 1.4× | – |
See a number that looks wrong?